Analyst: New UK monkeypox strategy might boost Bavarian Nordic orders

The UK plans to offer Bavarian Nordic’s vaccine, Imvanex, to a broader segment of people at risk of exposure. Wider use could lead to more orders from governments, assesses one analyst.
Photo: Dado Ruvic/Reuters/Ritzau Scanpix
Photo: Dado Ruvic/Reuters/Ritzau Scanpix
by marketwire, translated by daniel pedersen

On Tuesday, the UK announced plans to provide Bavarian Nordic’s vaccine, Imvanex, to a wider segment of people at-risk of exposure, including gay and bisexual men. Previously, vaccination was only recommended for those who had been in close contact with someone carrying the infection.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading